FDA Inspection 1007414 — LGM Pharma Solutions, LLC

LGM Pharma Solutions, LLC — FEI 3017140477

The FDA completed an inspection of LGM Pharma Solutions, LLC on December 13, 2016 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 13, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)